AAREYDRUGS
Trading
₹50.8
0.00 (0.00%)
| Market Cap | 108 Cr | EPS | 0.9 | High | 50.8 | ||
| Stock P/E | 45.6 | Net Profit Margin | 1.4 | Low | 50.75 |
Performance
Today’s Low
Today’s High
50.75
50.8
52W Low
52W High
22
55.1
| Open Price | 50.8 | Volume | 1 |
| Prev. Close | 50.8 |
Fundamentals
| Market Cap | 108 Cr | ROE | 3.3% | ||
| P/E Ratio(TTM) | 45.6 | EPS(TTM) | 0.0 | ||
| P/B Ratio | 0.9 | Dividend Yield | 0.0% | ||
| Industry P/E | 121.6 | Book Value | 46.8 | ||
| Face Value | 10.0 |
About the Company
Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.
The company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.
Product range of the company includes: API/Intermediate
- Metronidazol
- Metronidazole Benzoate
- 2 Methyl -5-Nitro Imidazole
Drug deliveryPharmaceuticals / Therapeutics
Therapeutic targets of the company's products are:
- Allergy
- Dermatology
- Infectious Diseases
Recent development
Aarey Drugs & Pharmaceuticals has recently informed that Atul A Zatakia has resigned from the Company as a Director with effect from March 01, 2009.
| Parent Organization | Aarey Drugs & Pharmaceuticals Ltd. | Managing Director | Mihir R Ghatalia | ||
| Founded | 1990 | NSE Symbol | AAREYDRUGS |
Financials
All values are in Rs Cr
Shareholding Pattern
Domestic Institutions
0.00%
Foreign Institutions
3.92%
Mutual Funds
0.00%
Promoters
50.03%
Domestic Institutions
0.00%
Foreign Institutions
3.92%
Mutual Funds
0.00%
Promoters
50.03%
Domestic Institutions
0.00%
Foreign Institutions
3.92%
Mutual Funds
0.00%
Promoters
50.03%
Domestic Institutions
0.00%
Foreign Institutions
3.92%
Mutual Funds
0.00%
Promoters
50.03%
Domestic Institutions
0.00%
Foreign Institutions
3.92%
Mutual Funds
0.00%
Promoters
50.03%
Peer Comparison
| Company | 52 Week | Market Price | P/E Ratio | Financials | Share Holding |
|---|---|---|---|---|---|
50.8(0.0%) | 45.6 | ||||
9.6(0.0%) | 0.0 | ||||
69.95(0.1%) | 107.7 | ||||
27.85(0.7%) | 36.9 |
